NCT03783182

Brief Summary

Betamethasone is currently given routinely in conjunction with tonsillectomy surgery at the majority of Ear, Nose \& Throat clinics in Sweden. The scientific evidence regarding the effects of betamethasone in adults is limited when it comes to postoperative nausea (PONV), pain and postoperative bleeding.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2019

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

September 10, 2019

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

5.8 years

First QC Date

November 15, 2018

Last Update Submit

May 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative nausea and vomiting

    Nausea/Vomiting postoperatively, numeric Visual Analogue Scale graded from 0 to 10, where 10 is the worst grade of nausea

    0-5 days postop

Secondary Outcomes (1)

  • Postoperative pain

    0-5 days postop

Other Outcomes (1)

  • Postoperative bleeding

    0-30 days postop

Study Arms (2)

Betapred

ACTIVE COMPARATOR

16 'Betamethason Sodium Phosphate' tablets dissolved in one ml of water as part of the premedications given to the patient 30 min before the surgery

Drug: Betamethason Sodium Phosphate

Placebo

PLACEBO COMPARATOR

One ml of 10% glucose solution as part of the premedications given to the patient 30 min before the surgery

Drug: 10% glucose solution

Interventions

Glucocorticoid

Also known as: Betapred
Betapred

Glucose solution that can be used for injection, but in this case it is used perorally (one ml)

Placebo

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent Age over 12 years Planned for elective bilateral tonsillectomy

You may not qualify if:

  • Insulin dependent diabetes mellitus
  • NSAID or corticosteroid intolerance
  • Pregnancy
  • Gastric ulcer
  • Immunodeficiency
  • Treatment for chronic pain
  • Psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunderby sjukhus

Luleå, 971 80, Sweden

RECRUITING

Related Publications (9)

  • Islam MR, Haq MF, Islam MA, Meftahuzzaman SM, Sarkar SC, Rashid H, Rashid HU. Preoperative use of granisetron plus dexamethasone and granisetron alone in prevention of post operative nausea and vomiting in tonsillectomy. Mymensingh Med J. 2011 Jul;20(3):386-90.

    PMID: 21804499BACKGROUND
  • McKean S, Kochilas X, Kelleher R, Dockery M. Use of intravenous steroids at induction of anaesthesia for adult tonsillectomy to reduce post-operative nausea and vomiting and pain: a double-blind randomized controlled trial. Clin Otolaryngol. 2006 Feb;31(1):36-40. doi: 10.1111/j.1749-4486.2006.01141.x.

    PMID: 16441800BACKGROUND
  • Stewart R, Bill R, Ullah R, McConaghy P, Hall SJ. Dexamethasone reduces pain after tonsillectomy in adults. Clin Otolaryngol Allied Sci. 2002 Oct;27(5):321-6. doi: 10.1046/j.1365-2273.2002.00588.x.

    PMID: 12383289BACKGROUND
  • Carr MM, Williams JG, Carmichael L, Nasser JG. Effect of steroids on posttonsillectomy pain in adults. Arch Otolaryngol Head Neck Surg. 1999 Dec;125(12):1361-4. doi: 10.1001/archotol.125.12.1361.

    PMID: 10604415BACKGROUND
  • Czarnetzki C, Elia N, Lysakowski C, Dumont L, Landis BN, Giger R, Dulguerov P, Desmeules J, Tramer MR. Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial. JAMA. 2008 Dec 10;300(22):2621-30. doi: 10.1001/jama.2008.794.

    PMID: 19066382BACKGROUND
  • Plante J, Turgeon AF, Zarychanski R, Lauzier F, Vigneault L, Moore L, Boutin A, Fergusson DA. Effect of systemic steroids on post-tonsillectomy bleeding and reinterventions: systematic review and meta-analysis of randomised controlled trials. BMJ. 2012 Aug 28;345:e5389. doi: 10.1136/bmj.e5389.

    PMID: 22930703BACKGROUND
  • Johansson U, Sundgren C, Tano K, van den Berg J. The effect of Perioperative Bethamethasone on Post-operative Nausea, Vomiting and Pain in Children undergoing Tonsillar Surgery. British Journal of Anaesthetic&Recovery Nursing. 2011;11:24-29.

    BACKGROUND
  • Bellis JR, Pirmohamed M, Nunn AJ, Loke YK, De S, Golder S, Kirkham JJ. Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis. Br J Anaesth. 2014 Jul;113(1):23-42. doi: 10.1093/bja/aeu152.

    PMID: 24942713BACKGROUND
  • Chu CC, Hsing CH, Shieh JP, Chien CC, Ho CM, Wang JJ. The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting. Eur J Pharmacol. 2014 Jan 5;722:48-54. doi: 10.1016/j.ejphar.2013.10.008. Epub 2013 Nov 1.

    PMID: 24184695BACKGROUND

MeSH Terms

Conditions

PainPostoperative Nausea and VomitingHemorrhage

Interventions

betamethasone sodium phosphate

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesNauseaSigns and Symptoms, DigestiveVomiting

Study Officials

  • Krister Tano, MD, PhD

    Umeå University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Krister Tano, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Administrator gives the study number and check the randomization list and thereafter gives the drug/placebo to a Health care personnel, who does not know if it is placebo or drug.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double-blinded, placebo controlled and randomized study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2018

First Posted

December 20, 2018

Study Start

September 10, 2019

Primary Completion

June 20, 2025

Study Completion

December 15, 2025

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations